Kolon Life Science Archives

Scandal-ridden Kolon TissueGene to be Delisted

SEOUL, Aug. 26 (Korea Bizwire) — The Korea Exchange, South Korea’s bourse operator, said Monday it has tentatively decided to delist Kolon TissueGene Inc., an affiliate of Kolon Life Science, from the local stock market as it submitted a false document when it was listed two years ago. But the company is allowed to seek [...]

Seoul Revokes License for Gene Therapy Drug Invossa

SEOUL, May 28 (Korea Bizwire) — South Korea’s drug authorities on Tuesday canceled the license for the gene therapy drug Invossa for the mislabeling and the false reporting of an ingredient used, sending a shock to patients and the country’s pharmaceuticals sector. The Ministry of Food and Drug Safety’s move came after the manufacturer, Kolon [...]